S. Seidu

First name
S.
Last name
Seidu
Shabnam, S., Gillies, C. L., Davies, M. J., Dex, T., Melson, E., Khunti, K., et al. (2023). Factors associated with therapeutic inertia in individuals with type 2 diabetes mellitus started on basal insulin. Diabetes Res Clin Pract, 203, 110888. http://doi.org/10.1016/j.diabres.2023.110888
Chudasama, Y. V., Khunti, K., Coles, B., Gillies, C. L., Islam, N., Rowlands, A. V., et al. (2023). Life expectancy following a cardiovascular event in individuals with and without type 2 diabetes: A UK multi-ethnic population-based observational study. Nutr Metab Cardiovasc Dis. http://doi.org/10.1016/j.numecd.2023.04.003
Abner, S., Gillies, C. L., Shabnam, S., Zaccardi, F., Seidu, S., Davies, M. J., et al. (2022). Consultation rates in people with type 2 diabetes with and without vascular complications: a retrospective analysis of 141,328 adults in England. Cardiovasc Diabetol, 21, 8. http://doi.org/10.1186/s12933-021-01435-y
Zaccardi, F., Jacquot, E., Cortese, V., Tyrer, F., Seidu, S., Davies, M. J., & Khunti, K. (2020). Comparative effectiveness of gliclazide modified release vs sitagliptin as second-line treatment after metformin monotherapy in patients with uncontrolled type 2 diabetes. Diabetes Obes Metab. http://doi.org/10.1111/dom.14169
Coles, B., Zaccardi, F., Seidu, S., Gillies, C. L., Davies, M. J., Hvid, C., & Khunti, K. (2021). Rates and estimated cost of primary care consultations in people diagnosed with type 2 diabetes and comorbidities: A retrospective analysis of 8.9 million consultations. Diabetes Obes Metab. http://doi.org/10.1111/dom.14340
Chudasama, Y. V., Zaccardi, F., Coles, B., Gillies, C. L., Hvid, C., Seidu, S., et al. (2021). Ethnic, social and multimorbidity disparities in therapeutic inertia: a UK primary care observational study in patients newly diagnosed with type 2 diabetes. Diabetes Obes Metab. http://doi.org/10.1111/dom.14482